메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

CorestemChemon Expands Global CRO Reach with ATG Lifetech, Targeting Next-Gen Preclinical Services

[ 메디채널 김갑성 기자 ] Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery SEOUL, South Korea, July 21, 2025 -- CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partnership with ATG Lifetech, a biotechnology company specializing in transcriptome analytics and organoid-based modeling. This collaboration aims to deliver next-generation, precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures across the U.S., Europe, and Asia.
- 김갑성 기자
- 2025-07-21 10:54
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel leadless system that provides cardiac resynchronization therapy to patients with heart failure. Cardiac resynchronization therapy improves the timing of the heart's contractions, helping to restore the normal rhythm of the heartbeat. The first procedure was recently performed by Robert Canby, M.D., cardiac electrophysiologist at TCAI. "This technology marks a significant advancem
- 김갑성 기자
- 2025-07-21 08:47
세인트 데이비드 메디컬 센터 산하 텍사스 심장부정맥연구소, FDA 승인 신기술 무선 시스템으로 심장 부정맥 치료 미국 최초 시행

오스틴, 텍사스, 2025년 7월 21일 -- 세인트 데이비드 메디컬 센터(St. David's Medical Center) 산하 텍사스 심장부정맥연구소(Texas Cardiac Arrhythmia Institute, TCAI)의 심장 전기생리학 전문의들이 심장 재동기화 치료를 제공하는 FDA 승인 신기술 무선 시스템을 미국 최초로 심부전 환자에게 이식하는 데 성공했다. 심장 재동기화 치료는 심장 수축 타이밍을 개선해 심장 박동을 정상 리듬으로 회복시키는 방법이다. 이번 첫 시술은 TCAI의 심장 전기생리학 전문의 로버트 캔비 박사(Robert Canby, M.D.)가 집도했다. TCAI의 심장 전기생리학자이자 의학총책임자인 안드레아 나탈레(Andrea Natale) 박사(F.H.R.S., F.A.C.C., F.E.S.C.)는 "이 기술은 이전까지 심장 재동기화 치료 선택지가 거의 없었던 환자들을 위한 치료 방식에 중대한 진전을 가져왔다"며, "텍사스 심장부정맥 연구소는 전 세계 환자들에게 가장 진보된 근거 기반 치료를 제공하는 데 전념하고 있으며, 캔비 박사의 리더십 덕분에 그 약속을 성공적으로 이행했다"라
- 김갑성 기자
- 2025-07-21 07:47
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management

BEIJING, July 18, 2025 -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity. Fangzhou's founder, chairman, and CEO Dr. Xie F
- 김갑성 기자
- 2025-07-18 20:04
AI-Powered Insurance and Healthcare: Waterdrop Inc. Included in Harvard Business School Case Collection

BEIJING, July 18, 2025 -- The business innovation case of Waterdrop Inc. (NYSE:WDH), Waterdrop: AI-Powered Insurance and Healthcare, was recently included in Harvard Business School (HBS)'s Case Collection, receiving recognition from this world-renowned academic institution. Developed by Professor Li Qi from the School of Management and Economics at The Chinese University of Hong Kong (Shenzhen), the case examines how Waterdrop has applied advanced AI technologies to drive systematic innovation and strategic transformation amid profound changes in the insurance and healthcare sectors. By fost
- 황정호 기자
- 2025-07-18 18:00
Scale Hits New High: HNC 2025 Concludes with Resounding Success, Driving a New Wave of Health Industry Upgrades

SHANGHAI, July 18, 2025 -- Jointly organized by the China Chamber of Commerce for Import & Export of Medicines & Health Products and Sinoexpo Informa Markets, the "Healthplex Expo 2025, Natural & Nutraceutical Products China 2025" (HNC 2025) was successfully held from June 24 to 26 at the National Exhibition and Convention Center (Shanghai). The HNC 2025 once again achieved a historic breakthrough in scale, winning high praise from all participants. Held concurrently with Hi & Fi Asia-China, ProPak China & FoodPack China, and Starch Expo, the HNC built a business
- 김갑성 기자
- 2025-07-18 17:03
DNAKE Emerges as a Global Innovator in Brain-Computer Interface Technology

XIAMEN, China, July 18, 2025 -- Brain-Computer Interface (BCI) technology is redefining human-machine interaction by establishing direct communication between the brain and external devices. This transformative innovation is driving profound societal impact across industries: revolutionizing neurological disease treatment (e.g., epilepsy, Parkinson's, and depression), enhancing educational outcomes through improved focus, and enabling seamless industrial human-robot collaboration. With aging populations and rising neurological disorders worldwide, BCI's healthcare applications are experiencin
- 김갑성 기자
- 2025-07-18 16:19
Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

GOTHENBURG, Sweden, July 18, 2025 -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 4.1% while order intake rose by 4.4% organically. Business area Acute Care Therapies continues to be successful in handling the increased demand for ventilators, and the order intake in ECLS consumables remains high. The
- 김갑성 기자
- 2025-07-18 14:29
The World Federation of Neurology to Host Global Webinar Uniting UN-ECOSOC, WHO and Leading Brain Health Experts for World Brain Day 2025, with the theme Brain Health for All Ages

LONDON, July 18, 2025 -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual World Brain Day, with the theme "Brain Health for All Ages." The official event of World Brain Day is a webinar, open to the public, taking place at 1:00 p.m. BST. World Brain Day is an annual event uniting the global community to protect and promote healthy brains. The webinar serves as a global call to action for both individuals, healthcare providers, non-governmental organizations, community leaders, policy-makers, and institutions to share meaningf
- 김갑성 기자
- 2025-07-18 14:00
Bowtie Secures Series C Fundraising From Sun Life

[ 메디채널 김갑성 기자 ] New Funding Fuels Growth in Medical Insurance and Innovation in Preventive Healthcare HONG KONG, July 18, 2025 -- Bowtie, Hong Kong's first virtual insurer[1], is proud to announce securing up to US$70 million in its Series C funding round. Led by Sun Life Hong Kong Limited ("Sun Life"), this marks the largest funding round for digital health insurers in Asia with a direct-to-consumer model. Bowtie continues to lead in Hong Kong's digital insurance market, ranking first in the direct channel[2], and securing the 9th position across all dist
- 김갑성 기자
- 2025-07-18 11:25

이전

41 42 43 44 45 46 47 48 49 50

많이 본 기사

최근기사

2025-09-01_MON

2025-08-31_SUN

2025-08-30_SAT

Global Trade Review Announces GTR Asia 2025 in Singapore - the premier platform for the trade community in the Asia Pacific region - hits over 1,500 registration for September 2-3 23:39

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 01일 09시 00분